Opzelura Ruxolitinib 1.5% Jar Price in Pakistan

Opzelura Ruxolitinib 1.5% Jar Price in Pakistan | SyedStore.Pk

Opzelura Ruxolitinib Cream 1.Five% is a prescription topical medication containing ruxolitinib, a Janus kinase (JAK) inhibitor. It is specially indicated for the topical remedy of nonsegmental vitiligo in adults and pediatric sufferers 12 years of age and older. By focused on JAK-associated signaling worried in the immune reaction, ruxolitinib can help support repigmentation of affected pores and skin. Opzelura is carried out at once to the affected regions and is usually used two times day by day according to a healthcare professional’s commands. Because it's miles a prescription medicine with important safety warnings, it have to be used below appropriate clinical supervision.

Key Benefits :

Indicated for nonsegmental vitiligo
Supports repigmentation of affected skin
Targets JAK1/JAK2-associated signaling
Convenient topical cream method
Non-steroidal topical remedy
Suitable for eligible patients 12 years and older under medical supervision

Key Features :

Contains ruxolitinib 1.Five% because the energetic component
Prescription topical remedy
JAK inhibitor that objectives specific immune-signaling pathways
Approved makes use of include certain cases of atopic dermatitis and nonsegmental vitiligo
Designed for software to affected pores and skin regions
Cream layout for topical use
Available % sizes may additionally vary through market and dealer

How to Use :

Use Opzelura simplest as prescribed by using your healthcare professional. Apply a skinny layer to the affected pores and skin areas according to the prescribed guidelines. Do now not use it on the eyes, mouth or vagina, and do no longer cowl dealt with regions with hermetic dressings unless particularly instructed via your clinician.

Why Choose Opzelura Ruxolitinib Cream ? :

Opzelura gives a targeted prescription treatment option for eligible patients with positive inflammatory skin situations or nonsegmental vitiligo. A healthcare professional can decide whether or not it is appropriate primarily based on the diagnosis, clinical history and different drugs being used.